IMS Health, a provider of market intelligence to the pharmaceutical and healthcare industries, has announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the United States.
IMS’s suite of information and advisory services enables clients to implement a fully integrated monitoring and reporting compliance infrastructure, providing an accurate view of their promotional spend associated with healthcare professionals. The services leverage the compliance application platform of R-Squared Services & Solutions, a developer of evidence-based compliance solutions for the healthcare and life sciences industries.
IMS Aggregate Spend Compliance Services enable clients to align and manage professional and organizational information across disparate systems and functions, effectively addressing the complexities in data capture, standardization, and integration, said Don Otterbein, IMS general manager, Business Transformation Services. "Our solution also includes a flexible and scalable reporting system, allowing for quick response to evolving regulations and reporting requirements,” he said.
IMS Aggregate Spend Compliance Services bring together the capabilities of the IMS Business Transformation Services organization, which leverages the company’s expertise in business and compliance technology; IMS Healthcare Relational Services, which combines the company’s reference data and advisory services for an accurate view of healthcare professionals; and R-Squared’s SpendTracker software, a flexible, scalable platform that can be augmented as regulations change, delivering custom reports to satisfy companies’ internal policies.